Plan to speed up antibiotic approval debated by experts

Federal officials, medical experts and drugmakers are calling for faster approval of new antibiotics to deal with outbreaks of drug-resistant bacteria. Long trials should give way to direct and faster testing in very ill patients as the need for new antibiotics is critical, according to supporters of an overhaul. The Infectious Diseases Society of America proposed a special label and limits for new antibiotics approved through quicker testing, but critics argue that short trials might not be able to adequately assess effectiveness and safety.

View Full Article in:

New York Times (tiered subscription model), The

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Financial Officer
B. E. Smith
Miramar, FL
Claims Director
PacificSource
Springfield, OR
Consultant
Attest Health Care Advisors
Nationwide, SL_Nationwide
Biotechnology/Pharmaceutical Patent Attorney
Coats and Bennett PLLC
Cary, NC
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA